A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer

Autor: Albanes, Demetrius, Arslan, Alan A., Gurrea, Aurelio Barricarte, Beane-Freeman, Laura, Bracci, Paige M., Bueno-de-Mesquita, Bas, Buring, Julie, Canzian, Federico, Gallinger, Stephen, Gaziano, J. Michael, Giles, Graham G., Goodman, Phyllis J., Johansson, Mattias, Kooperberg, Charles, LeMarchand, Loic, Malats, Nuria, Neale, Rachel E., Panico, Salvatore, Peters, Ulrike, Real, Francisco X., Shu, Xiao-Ou, Sund, Malin, Thornquist, Marc, Tjønneland, Anne, Travis, Ruth C., Van Den Eeden, Stephen K., Visvanathan, Kala, Zheng, Wei, Kraft, Peter, Jermusyk, Ashley, Zhong, Jun, Connelly, Katelyn E., Gordon, Naomi, Perera, Sumeth, Abdolalizadeh, Ehssan, Zhang, Tongwu, O’Brien, Aidan, Hoskins, Jason W., Collins, Irene, Eiser, Daina, Yuan, Chen, Risch, Harvey A., Jacobs, Eric J., Li, Donghui, Du, Mengmeng, Stolzenberg-Solomon, Rachael Z., Klein, Alison P., Smith, Jill P., Wolpin, Brian M., Chanock, Stephen J., Shi, Jianxin, Petersen, Gloria M., Westlake, Christopher J., Amundadottir, Laufey T.

Publikováno v: In The American Journal of Human Genetics 7 October 2021 108(10):1852-1865